|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 AUD | -6.67% |
|
+18.31% | +21.74% |
| Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
| Apr. 24 | Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B | CI |
Immutep Limited announced that its registered office and principal place of business has changed with immediate effect to: Level 32, Australia Square, 264 George Street, Sydney, NSW 2000, Australia.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.74% | 326M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
IMMUTEP LIMITED 
